New therapies pack a triple-drug punch to treat cystic fibrosis

The approach, still in clinical trials, might one day provide relief to many with the disease

patient breathing oxygen

TO BREATHE EASIER  In clinical trials, two triple-drug therapies improved lung function for cystic fibrosis patients who have the most common disease-causing mutation.


This article is only available to Science News subscribers.

Subscribers, enter your e-mail address to access our archives.

Not a subscriber?

Science News is a nonprofit.

Support us by subscribing now.

More Stories from Science News on Health & Medicine

From the Nature Index

Paid Content